cryptocurrency service Top Overview

Rifa Seiki: Xunmi Technology went to the company to investigate and discuss products such as end-horizontal machining center and thread grinder. On December 11th, Xunmi Technology co-president Lei Ming and his party visited and investigated Seiki Seiki in Japan. Chasing technology has visited the production workshop of Maichuang and bearing equipment in depth, and gained an in-depth understanding of the specific situation of products such as high-end horizontal machining center and thread grinder of Nissan Seiki from research and development to production. Not only that, the two sides also conducted in-depth exchanges and discussions on the intelligent production line structure, core components, product accuracy and related issues in the practical application of a complete set of solutions. According to the data, Chasing Technology began to lay out robots in 2021, and successively launched bionic quadruped robot dogs, universal humanoid robots and other products. In September this year, Xunmi Technology released X50 series sweeping robots, equipped with the world's first "bionic mechanical foot obstacle-crossing technology".PETER LAMELAS was nominated by Trump as the US ambassador to Argentina.Evergrande Group and others were resumed execution by 320 million yuan. According to the information of legal proceedings, on December 11th, Evergrande Group Co., Ltd. added two pieces of resumption execution information, with a total execution amount of more than 322 million yuan, involving construction project contract disputes. The executors also included Hefei Yuetai Commercial Operation Management Co., Ltd. and Evergrande Real Estate Group Co., Ltd., and the enforcement court was the Baohe District People's Court in Hefei.

Shennong Group has set up a new trading subsidiary in Guangxi. The enterprise search APP shows that recently, Guangxi Shennong Haiyun Trading Co., Ltd. was established, with the legal representative of He Xinyang and the registered capital of 10 million yuan. Its business scope includes: electronic product sales; Non-metallic minerals and products sales; Building materials sales, etc. Enterprise equity penetration shows that the company is wholly owned by Shennong Group.In 2024, the qualification examination and approval of the first batch of new materials insurance compensation was started, and the Ministry of Industry and Information Technology recently issued a notice to organize the qualification examination and approval of the first batch of new materials insurance compensation in 2024. It is clear that the enterprise applying for qualification should be an enterprise that produces and manufactures the products listed in the Catalogue for the Demonstration and Guidance of the First Application of Key New Materials (2024 Edition). It belongs to an independent legal person registered in People's Republic of China (PRC), has strong design and development, manufacturing and industrialization capabilities, has a relatively complete team of professional technicians, and has mastered the core technology and intellectual property rights of this product development. The qualification examination and approval procedures need to go through three steps: enterprise declaration, review by local industrial and information authorities or recommended units such as the central enterprise group, and expert review organized by the Ministry of Industry and Information Technology. After review, the product compensation qualification is determined, and the amount of subsidy funds is approved according to a certain proportion of the product value, and the effective period is no more than 3 years.Chuanrun helps Goldwind Technology roll off the production line of a new generation of deep-sea 22MW offshore wind turbines. According to Sichuan Chuanrun Co., Ltd., recently, Goldwind Technology successfully rolled off the production line of a new generation of deep-sea 22MW offshore wind turbines in Shantou manufacturing base, setting a new record for Guangdong's largest single-unit capacity offshore wind turbines. As a key technical partner, Chuanrun provided a complete set of cooling system and lubrication system for the unit, which demonstrated the company's technical strength and innovation ability in the field of wind power.

FTSE China A50 index futures rose 1%.The first phase of the East Middle Route of South-to-North Water Diversion Project has transferred more than 76.7 billion cubic meters of water. The the State Council Information Office held a press conference at 10: 00 this morning. The relevant person in charge of the Ministry of Water Resources announced that the first phase of the East Middle Route of South-to-North Water Diversion Project has transferred more than 76.7 billion cubic meters of water since the tenth anniversary of the full water supply. The guarantee rate of urban living and industrial water supply along the line has been significantly improved. The water supply area of the project has been continuously extended, benefiting 185 million people in 45 large and medium-sized cities. The level of saving and intensive utilization of water resources in the receiving area has been comprehensively improved, and the overall level of water use efficiency is in the forefront of the country.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.